June 29, 2018
CHMP recommends approval of Sanofi’s Cablivi
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Cablivi (caplacizumab) in Europe…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Sanofi Genzyme
April 5, 2017
Sanofi welcomes new EVP
Sanofi has appointed Bill Sibold, a current head of Sanofi Genzyme’s Global Multiple Sclerosis, Oncology and Immunology organization, as Executive Vice President Sanofi Genzyme and member of the Executive Committee, effective July 1, 2017.
December 8, 2016
EMA to review Sanofi/Regeneron’s skin disease treatment Dupixent
Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application…